Las ballenas de altcoins están comprando después del desplome de las criptomonedas a principios de noviembre

The early-November crypto crash caught many off-guard, wiping out billions in value and triggering widespread panic selling. Yet, amid the chaos, whales—those high-net-worth investors with deep pockets—are quietly positioning for the rebound by accumulating select altcoins showing resilience and technical promise. Based on on-chain data, three stand out: Aster (ASTER), Bio Protocol (BIO), and Syrup (SYRUP). These tokens are attracting big money due to breakout patterns, bullish divergences, and undervaluation, offering potential 50-100% upside if the market stabilizes. Let’s break down the whale activity and what it means for your portfolio.

Aster (ASTER): 12.6% Whale Accumulation Signals Breakout Potential

Aster (ASTER), a decentralized perpetuals trading protocol on BNB Chain, is seeing aggressive whale buying, with large holders increasing positions by 12.6% in the last 24 hours to 43.62 million tokens (valued at $5.46 million). This accumulation, despite a 10% weekly dip, highlights ASTER’s strength amid the crash, as whales eye its RSI divergence and potential breakout above $1.53 toward $2.21. With a 1,900% surge since September and backing from influential figures, ASTER’s low 0.17 volume-to-cap ratio suggests it’s undervalued, making it a prime whale target for November gains.

• Whale Move: +4.9 million tokens ($5.46M); 12.6% increase.
• Technical Setup: RSI divergence; $1.53 breakout targets $2.21.
• Why Buy?: Backed by high-profile support; 73% upside potential.

Bio Protocol (BIO): 87% Whale Spike Amid OBV Breakout

Bio Protocol (BIO), a DeFi yield protocol on Ethereum, has captured whale attention with a 87% increase in large-holder accumulation, adding 2.97 million BIO in 24 hours. This surge coincides with an OBV (On-Balance Volume) breakout, pointing to $0.097 as the next target, with invalidation below $0.066. BIO’s neutral performance against top cryptos and 11% weekly gain make it a stealth play, as whales bet on its staking emissions and LP rewards in a recovering market. With 73% upside from current levels, BIO’s 40.20% 7-day drop from highs is viewed as a dip-buy opportunity.

• Whale Move: +2.97 million BIO (87%); $0.097 target.
• Technical Setup: OBV breakout; support $0.066.
• Why Buy?: Yield farming appeal; 73% short-term upside.

Syrup (SYRUP) : $11.5M Whale Inflows Eye $0.46 Surge

Syrup (SYRUP), a governance token for Maple Finance’s RWA lending on Ethereum, is another whale darling, with large holders scooping up 28 million tokens ($11.5 million) in 48 hours. The RSI-CMF combination signals a potential move to $0.46, with $0.36 support holding firm. Syrup’s 15% weekly gain and neutral trend against peers reflect confidence in its revenue-sharing and staking model, making it a low-risk accumulation amid the crash. With 60% of supply staked, the 73% upside from lows positions Syrup as a steady rebound candidate.

• Whale Move: +28 million tokens ($11.5M); $0.46 target.
• Technical Setup: RSI-CMF combo; support $0.36.
• Why Buy?: RWA lending growth; 73% upside from lows.

Why Whales Are Buying Now: A Crash = Opportunity Play

Whales thrive on volatility, and the early-November crash—triggering $1.1 billion in liquidations and 303,000 traders wiped out—is their hunting ground. On-chain data shows 50% exchange balance drops and 1,350 whale entities at lows, indicating distribution followed by accumulation. With Bitcoin dominance at 60% and ETF outflows at $799 million, altcoins like Aster, Bio, and Syrup offer asymmetric upside: 73-1250% potential from oversold levels. As Fed jitters (65% December cut odds) ease, whales’ 12-87% allocations signal a rebound, with RSI divergences and OBV breakouts confirming momentum.